Global Pneumonia Testing Market Size, Trends, By Types (Consumables and Analyzers), By Method (Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing), By Technology (Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Pneumonia Testing Market
The Global Pneumonia Testing Market was valued at US$ 1.8 Bn in 2022, estimated to reach US$ 3.0 Bn by 2030, with a CAGR of 12.13% from 2023-2030.
The symptoms of pneumonia, a complex infection that affects the lower respiratory tract, include shortness of breath, fever, chest pain, nausea, and vomiting. During pneumonia, fluid or pus-filled alveoli, the lungs' air sacs, inflame, causing pneumonia. It is frequently found in children and the elderly population and is primarily brought on by microorganisms such as bacteria, viruses, fungi, and parasites. It affects persons with low immune systems.
The intensity of the symptoms and types of infections affect how pneumonia is treated. Pneumonia brought on by bacterial infections is treated with antibiotics. When fungi are the cause of pneumonia, antifungals are recommended.
Market Drivers
The market is expanding as a result of the development of immunochromatographic, pneumococcal urinary antigen (UAT), and enhanced nucleic acid detection tests. Additionally, more people are being tested for pneumonia around the world due to increased public awareness of the advantages of early detection. This, together with the increased amount of money that governments in various nations are spending on healthcare, is causing the industry to expand.
Additionally, due to its great sensitivity and simplicity of use, the enzyme-linked immunosorbent test (ELISA) is being used to identify pneumonia. The aging population and the increased incidence of pediatric pneumonia globally are two additional growth-promoting factors.
Market Restraints
Cultures are still mostly utilized in the old method, which has a higher mistake rate, to identify pneumonia-causing organisms. This can restrain market growth to some extent throughout the projection period.
Market Segmentation
The scope of the Global Pneumonia Testing Market covers segmentation based on Product Type, Formulation, Therapeutic Area, and Region.
Based on Types, the market is classified into Consumables and Analyzers.
Based on Method, the market is segmented into Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing.
Based on Technology, the market is classified into Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry, and Others.
Regional Analysis
The Global Pneumonia Testing Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Due to the region's growing geriatric population, North America is predicted to hold a significant market share in the worldwide Pneumonia Testing market. Pneumonia, for example, is the eighth most common cause of death in the United States, according to the Centres for Disease Control and Prevention, which has increased awareness of the illness and fueled the market for pneumonia tests.
The overall market in this region is also being driven by increased product approval and rising product launches. For instance, BioMérieux's FilmArray Respiratory Panel 2 (RP2) from BioFire has FDA clearance. Additionally, the expansion of the regional market as a whole is being greatly aided by rising healthcare costs and the presence of an established healthcare infrastructure.
Key Players
Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., BioMerieux, Becton, Dickenson and The company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Market Taxonomy
By Types
• Consumables
• Analyzers
By Method
• Immunodiagnostics
• Molecular Diagnostics
• Point of Care Testing
By Technology
• Enzyme Linked Immunosorbant Assay
• Immunofluoroscence
• Western Blot
• Polymerase Chain Reaction
• Imunohistochemistry
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Pneumonia Testing Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Pneumonia Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Pneumonia Testing Market, By Types
5.1 Y-o-Y Growth Comparison, By Method and Services
5.2 Global Pneumonia Testing Market Share Analysis, By Types
5.3 Global Pneumonia Testing Market Size and Forecast, By Types
5.3.1 Consumables
5.3.2 Analyzers
6 Global Pneumonia Testing Market, By Method
6.1 Y-o-Y Growth Comparison, By Method
6.2 Global Pneumonia Testing Market Share Analysis, By Method
6.3 Global Pneumonia Testing Market Size and Forecast, By Method
6.3.1 Immunodiagnostics
6.3.2 Molecular Diagnostics
6.3.3 Point of Care Testing
7 Global Pneumonia Testing Market, By Technology
7.1 Y-o-Y Growth Comparison, By Technology
7.2 Global Pneumonia Testing Market Share Analysis, By Technology
7.3 Global Pneumonia Testing Market Size and Forecast, By Technology
7.3.1 Enzyme Linked Immunosorbant Assay
7.3.2 Immunofluoroscence
7.3.3 Western Blot
7.3.4 Polymerase Chain Reaction
7.3.5 Imunohistochemistry
7.3.6 Others
8 Global Pneumonia Testing Market, By Region
8.1 Global Pneumonia Testing Market Share Analysis, By Region
8.2 Global Pneumonia Testing Market Size and Forecast, By Region
8.3 Global Pneumonia Testing Market Trends and Forecast, By Region
9 North America Pneumonia Testing Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Pneumonia Testing Market Share Analysis, By Types
9.3 North America Pneumonia Testing Market Size and Forecast, By Method
9.4 North America Pneumonia Testing Market Size and Forecast, By Technology
9.5 North America Pneumonia Testing Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Types
9.5.1.2 Market Size and Forecast, By Method
9.5.1.3 Market Size and Forecast, By Technology
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Types
9.5.2.2 Market Size and Forecast, By Method
9.5.2.3 Market Size and Forecast, By Technology
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Types
9.5.3.2 Market Size and Forecast, By Method
9.5.3.3 Market Size and Forecast, By Technology
10 Europe Pneumonia Testing Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Pneumonia Testing Market Share Analysis, By Types
10.3 Europe Pneumonia Testing Market Size and Forecast, By Method
10.4 Europe Pneumonia Testing Market Size and Forecast, By Technology
10.5 Europe Pneumonia Testing Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Types
10.5.1.2 Market Size and Forecast, By Method
10.5.1.3 Market Size and Forecast, By Technology
10.5.2 France
10.5.2.1 Market Size and Forecast, By Types
10.5.2.2 Market Size and Forecast, By Method
10.5.2.3 Market Size and Forecast, By Technology
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Types
10.5.3.2 Market Size and Forecast, By Method
10.5.3.3 Market Size and Forecast, By Technology
10.5.4. Russia
10.5.4.1 Market Size and Forecast, By Types
10.5.4.2 Market Size and Forecast, By Method
10.5.4.3 Market Size and Forecast, By Technology
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Types
10.5.5.2 Market Size and Forecast, By Method
10.5.5.3 Market Size and Forecast, By Technology
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Types
10.5.6.2 Market Size and Forecast, By Method
10.5.6.3 Market Size and Forecast, By Technology
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Types
10.5.7.2 Market Size and Forecast, By Method
10.5.7.3 Market Size and Forecast, By Technology
11 Asia Pacific Pneumonia Testing Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Pneumonia Testing Market Share Analysis, By Types
11.3 Asia Pacific Pneumonia Testing Market Size and Forecast, By Method
11.4 Asia Pacific Pneumonia Testing Market Size and Forecast, By Technology
11.5 Asia Pacific Pneumonia Testing Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Types
11.5.1.2 Market Size and Forecast, By Method
11.5.1.3 Market Size and Forecast, By Technology
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Types
11.5.2.2 Market Size and Forecast, By Method
11.5.2.3 Market Size and Forecast, By Technology
11.5.3 India
11.5.3.1 Market Size and Forecast, By Types
11.5.3.2 Market Size and Forecast, By Method
11.5.3.3 Market Size and Forecast, By Technology
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Types
11.5.4.2 Market Size and Forecast, By Method
11.5.4.3 Market Size and Forecast, By Technology
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Types
11.5.5.2 Market Size and Forecast, By Method
11.5.5.3 Market Size and Forecast, By Technology
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Types
11.5.6.2 Market Size and Forecast, By Method
11.5.6.3 Market Size and Forecast, By Technology
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Types
11.5.7.2 Market Size and Forecast, By Method
11.5.7.3 Market Size and Forecast, By Technology
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Method and Services
11.5.8.2 Market Size and Forecast, By Method
11.5.8.3 Market Size and Forecast, By Technology
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Types
11.5.9.2 Market Size and Forecast, By Method
11.5.9.3 Market Size and Forecast, By Technology
12 Latin America Pneumonia Testing Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Pneumonia Testing Market Share Analysis, By Types
12.3 Latin America Pneumonia Testing Market Size and Forecast, By Method
12.4 Latin America Pneumonia Testing Market Size and Forecast, By Technology
12.5 Latin America Pneumonia Testing Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Types
12.5.1.2 Market Size and Forecast, By Method
12.5.1.3 Market Size and Forecast, By Technology
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Types
12.5.2.2 Market Size and Forecast, By Method
12.5.2.3 Market Size and Forecast, By Technology
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Types
12.5.3.2 Market Size and Forecast, By Method
12.5.3.3 Market Size and Forecast, By Technology
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Types
12.5.4.2 Market Size and Forecast, By Method
12.5.4.3 Market Size and Forecast, By Technology
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Types
12.5.5.2 Market Size and Forecast, By Method
12.5.5.3 Market Size and Forecast, By Technology
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Types
12.5.6.2 Market Size and Forecast, By Method
12.5.6.3 Market Size and Forecast, By Technology
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Types
12.5.7.2 Market Size and Forecast, By Method
12.5.7.3 Market Size and Forecast, By Technology
13 Middle East Pneumonia Testing Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Pneumonia Testing Market Share Analysis, By Types
13.3 Middle East Pneumonia Testing Market Size and Forecast, By Method
13.4 Middle East Pneumonia Testing Market Size and Forecast, By Technology
13.5 Middle East Pneumonia Testing Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Types
13.5.1.2 Market Size and Forecast, By Method
13.5.1.3 Market Size and Forecast, By Technology
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Types
13.5.2.2 Market Size and Forecast, By Method
13.5.2.3 Market Size and Forecast, By Technology
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Types
13.5.3.2 Market Size and Forecast, By Method
13.5.3.3 Market Size and Forecast, By Technology
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Types
13.5.4.2 Market Size and Forecast, By Method
13.5.4.3 Market Size and Forecast, By Technology
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Types
13.5.5.2 Market Size and Forecast, By Method
13.5.5.3 Market Size and Forecast, By Technology
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Types
13.5.6.2 Market Size and Forecast, By Method
13.5.6.3 Market Size and Forecast, By Technology
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Thermo Fisher Scientific Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 F-Hoffmann la Roche Ltd.
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Hologic Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 BioMerieux
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Becton
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Dickenson and Company
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Bio-Rad Laboratories Inc.
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Meridian Biosciences
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Quest Diagnostics
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
